New Pain Drug in Development (The Pharm Voice)
Corgentec's pain drug 4975 showed efficacy in a recent Phase II trial. In her entry, blogger Gloria Gamat writes about the study.
Hindrances (In the Pipeline)
Sometimes, research takes longer than it should due to human error. Blogger Derek Lowe writes about the "Waste O' Time Awards" in his entry, citing a specific viral protease study.